Anti-IL-23 Antibody (Brazikumab)
Catalog No.
F1267
Anti-IL-23 Antibody (Brazikumab)
Featured Products
Brazikumab (AMG 139) is a human IgG2 monoclonal antibody that selectively binds to the p19 subunit of IL-23 with a KD value of 0.138 nM for human IL-23. Brazikumab can be used for the study of Crohn's disease.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
144.82 kDa
Dry ice
1610353-18-8
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
AMG 139, MEDI2070, MEDI-2070
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q9NPF7
Human
Unconjugated
Monoclonal
Protein A
IgG2SA
ELISA, FACS, Kinetics, Functional assay, Animal Model
IL-23
Please avoid freeze-thaw cycles.